What is aTyr Pharma's current debt?

aTyr Pharma (ATYR) reported current debt of $596K in Q1 2026.

How has aTyr Pharma's current debt changed year-over-year?

aTyr Pharma's current debt increased by 8.4% year-over-year, from $550K to $596K.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

aTyr Pharma ATYR Current Debt

Current Debt at other companies

Bristol-Myers SquibbBMY

$2.31B-35.1%

Rigel PharmaceuticalsRIGL

$22.5M—

Syndax PharmaceuticalsSNDX

$350M+4.2%

Nuvation BioNUVB

$5.79M+1.8%

Sarepta Therapeutics, Inc.SRPT

$0-100%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's current debt?: aTyr Pharma (ATYR) reported current debt of $596K in Q1 2026.
How has aTyr Pharma's current debt changed year-over-year?: aTyr Pharma's current debt increased by 8.4% year-over-year, from $550K to $596K.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.